A Study of Single and Repeated Doses of LY3556050 in Healthy Participants

NCT05341102 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3556050
DRUG: Placebo

Sponsor

Eli Lilly and Company